Financials

  • Market Capitalization 1.83 B
  • Employee 367
  • Founded 2016
  • CEO Marianne De Backer
  • Website www.vir.bio
  • Headquarter Delaware, United States
  • FIGI BBG00H2QQ8T5
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.48
Rapporto prezzo/fatturato
5.42

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2045
IMCR
Immunocore Holdings plc - American Depositary Shares
36.62 USD-0.35%-0.38%+7.71%+9.38%1.89 B USD
2048
TSHA
Taysha Gene Therapies, Inc. - Common Stock
5.77 USD-3.19%-4.15%-1.87%+98.97%1.88 B USD
2070
INBX
Inhibrx Biosciences, Inc. - Common Stock
123.41 USD-0.42%+17.53%+50.50%+53.15%1.82 B USD
2071
SEPN
Septerna, Inc. - Common Stock
38.91 USD-3.85%-3.31%+11.27%+76.78%1.82 B USD

Notizie